MedTrace Logo

Treatment of Chronic Medium-severe Periodontitis With Mesenchymal Stem Cells Predifferentiated in Osteogenic Direction

NCT04446897 · Status: COMPLETED · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2021-02-09

No results posted yet for this study

Summary

Treatment of chronic medium-severe periodontitis with mesenchymal stem cells and mesenchymal stem cells predifferentiated in osteogenic direction

Conditions

  • Periodontitis, Chronic

Interventions

BIOLOGICAL

mesenchymal stem cells

autologous mesenchymal stem cells

OTHER

standard treatment

standard treatment according to clinical protocols

Sponsors & Collaborators

  • Belarusian Medical Academy of Post-Graduate Education

    collaborator OTHER

  • Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus

    lead OTHER_GOV

Principal Investigators

  • Igor Volotovski, Prof · Head of the Lab of Institute of Biophysics and Cell Engineering

  • Sergey Rubnikovich, Prof · Head of the Department of Prosthodontics of BMAPE

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
70 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-08-03
Primary Completion
2020-12-31
Completion
2020-12-31

Countries

  • Belarus

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04446897 on ClinicalTrials.gov